AVNS
AVNS
NYSE · Health Care

Avanos Medical Inc

$24.71
+0.00 (+0.00%)
Financial Highlights (FY 2026)
Revenue
707.00M
Net Income
-73,502,675
Gross Margin
50.5%
Profit Margin
-10.4%
Rev Growth
-5.1%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 50.5% 50.5% 62.5% 62.5%
Operating Margin -8.8% -7.9% 19.2% 18.9%
Profit Margin -10.4% -9.9% 15.7% 17.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 707.00M 744.84M 134.83M 155.65M
Gross Profit 356.82M 375.92M 84.30M 97.32M
Operating Income -62,074,849 -58,857,315 25.89M 29.38M
Net Income -73,502,675 -69,692,801 21.13M 26.73M
Gross Margin 50.5% 50.5% 62.5% 62.5%
Operating Margin -8.8% -7.9% 19.2% 18.9%
Profit Margin -10.4% -9.9% 15.7% 17.2%
Rev Growth -5.1% -5.1% +2.6% +23.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 66.19M 66.19M 313.58M 310.39M
Total Equity 512.68M 512.68M 338.13M 361.58M
D/E Ratio 0.13 0.13 0.93 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -22,888,765 -22,908,055 34.86M 46.09M
Free Cash Flow 16.58M 14.70M